Pfizer Reports 95% Success Rate in COVID-19 Vaccine Final Trial

Final results from Pfizer Inc.’s COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on …

from News – Insurance Journal https://ift.tt/32QOyy3
via IFTTT